For the first time, we have demonstrated that molecular heterogeneity in the response to immunotherapy in East Asian NSCLC patients was correlated with the tumor immune microenvironment based on PD-L1 expression, TIL presence, and the local repertoire of tumor infiltrating leukocytes. Here, CD274 is linked to neoplasm.